Abstract

This review will describe and update readers on the recent changes in the 2017 WHO classification regarding peripheral T-cell lymphomas. Signficant advances in molecular studies have resulted in revisions to the classification as well as introduction to provisional entities such as breast implant-associated ALCL and nodal PTCL with T-follicular helper phenotype. Major advances in molecular and gene expression profiling has expanded our knowledge of these rare and aggressive diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call